These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36946434)
1. Diagnosing mycosis fungoides after initiation of therapy with dupilumab: a case report and literature review. Yan D; Ramachandran V; Weston G; Kim RH; Latkowski JA Int J Dermatol; 2023 Sep; 62(9):e500-e503. PubMed ID: 36946434 [No Abstract] [Full Text] [Related]
2. Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment. Joshi TP; Duvic M J Am Acad Dermatol; 2023 Jun; 88(6):e305-e306. PubMed ID: 36858155 [No Abstract] [Full Text] [Related]
3. Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review. Jfri A; Smith JS; Larocca C J Am Acad Dermatol; 2023 May; 88(5):1164-1166. PubMed ID: 36481378 [No Abstract] [Full Text] [Related]
4. Dupilumab, Atopic Dermatitis, and Mycosis Fungoides-New Insights on an Evolving Story. Guitart J JAMA Dermatol; 2023 Nov; 159(11):1177-1178. PubMed ID: 37851433 [No Abstract] [Full Text] [Related]
5. Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides. Wang J; Ram-Wolff C; Dobos G; Al Hage J; Grange F; Rivet J; Vignon-Pennamen MD; Moins-Teisserenc H; Boisson M; Moegle C; Sadoux A; Mourah S; Battistella M; Bagot M; de Masson A Br J Dermatol; 2022 Jul; 187(1):129-131. PubMed ID: 35083741 [No Abstract] [Full Text] [Related]
6. Alemtuzumab induced complete remission of romidepsin-refractory large cell transformation of mycosis fungoides. Kwong YL Ann Hematol; 2014 Apr; 93(4):713-4. PubMed ID: 23934231 [No Abstract] [Full Text] [Related]
7. Progression of mycosis fungoides after treatment with dupilumab: A case report. Miyashiro D; Vivarelli AG; Gonçalves F; Cury-Martins J; Sanches JA Dermatol Ther; 2020 Nov; 33(6):e13880. PubMed ID: 32558148 [No Abstract] [Full Text] [Related]
8. A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy. Postorino M; Pupo L; Provenzano I; Del Principe MI; Buccisano F; Franceschini L; Rizzo M; Nasso D; Meconi F; Onnis I; Vaccarini S; Zizzari A; Anemona L; Mauramati S; Bruno E; Cantonetti M; Amadori S Ann Hematol; 2016 Jan; 95(1):153-154. PubMed ID: 26442854 [No Abstract] [Full Text] [Related]
9. Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides. Fountain E; Mistry H; Jain P; Duvic M; Fowler N Leuk Lymphoma; 2019 Apr; 60(4):1079-1082. PubMed ID: 30301395 [No Abstract] [Full Text] [Related]
10. Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis. Chiba T; Nagai T; Osada SI; Manabe M Acta Derm Venereol; 2019 Jul; 99(9):818-819. PubMed ID: 31045233 [No Abstract] [Full Text] [Related]
11. Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report. Lolli G; Casadei B; Argnani L; Pileri A; Pellegrini C; Zinzani PL Acta Haematol; 2022; 145(2):207-209. PubMed ID: 34818217 [TBL] [Abstract][Full Text] [Related]
12. Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab. Newsom M; Hrin ML; Hamid RN; Strowd LC; Ahn C; Jorizzo JL; Feldman SR Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560800 [No Abstract] [Full Text] [Related]